National survey of the impact of drug shortages in acute care hospitals

American Journal of Health-System Pharmacy

Volumn 61, Issue 19, 2004, Pages 2015-2022

  Baumer, Amanda M ^a,b   Clark, Angela M ^c   Witmer, David R ^d   Geize, Shirley B ^c   Vermeulen, Lee C ^e   Deffenbaugh, Joseph H ^f  

^a ELI LILLY AND COMPANY   (United States)

^b JOHNS HOPKINS HOSPITAL   (United States)

^c JHH   (United States)

^d AMERICAN SOCIETY OF HEALTH SYSTEM PHARMACISTS   (United States)

^e University of Wisconsin Health   (United States)

^f ASHP   (United States)

Author keywords

Compounding; Costs; Data collection; Drug distribution; Economics; Patient care; Pharmacists, hospital; Pharmacy, institutional, hospital

Indexed keywords

BETAMETHASONE; FENTANYL; FUROSEMIDE; HEPARIN; HYALURONIDASE; MEROPENEM; METHYLPREDNISOLONE; PIPERACILLIN PLUS TAZOBACTAM; PROCHLORPERAZINE;

COST BENEFIT ANALYSIS; DATA BASE; DRUG COST; DRUG MARKETING; DRUG PREFERENCE; HEALTH CARE MANAGEMENT; HOSPITAL; HOSPITAL FINANCE; HOSPITAL PHARMACY; HOSPITAL PURCHASING; HUMAN; INJECTION; INTERNET; PATIENT CARE; PHARMACIST; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; REVIEW;

EID: 8344233313     PISSN: 10792082     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajhp/61.19.2015     Document Type: Review

References (17)

1. American Society of Health-System Pharmacists. Provisional observations on drug product shortages: effects, causes, and potential solutions. Summary of a stakeholders' meeting on drug shortages convened by the American Medical Association and the American Society of Health-System Pharmacists, Washington, D.C., July 12, 2002. Am J Health-Syst Pharm. 2002; 59:2173-82.
2. Witmer DR, Deffenbaugh J. The pharmaceutical supply chain: a perfect storm is brewing. Am J Health-Syst Pharm. 2004; 61:143. Editorial.
3. Chisholm CD, Klanduch F. Inadvertent administration of sufentanil instead of fentanyl during sedation/analgesia in a community hospital emergency department: a report of two cases. Acad Emerg Med. 2000; 7:1282-4.
4. Sterile drug products found to be contaminated. Pharm Link. 2001; 7:1-2.
5. Wellman GS. National supply-chain survey of drug manufacturer back orders. Am J Health-Syst Pharm. 2001; 58:1224-8.
6. Gebhart F. What's behind the recent rash of drug shortages? Drug Top. 2000; 144(5):50.
7. Fox ER, Tyler LS. Managing drug shortages: seven years' experience at one health system. Am J Health-Syst Pharm. 2003; 60:245-53.
8. Willis GB, Royston P, Bercini D. The use of verbal reporting methods in the development and testing of survey questionnaires. Appl Cogn Psychol. 1991; 5:251-67.
9. Willis GB. Cognitive interviewing and questionnaire design: a training manual. Bethesda, MD: National Center for Health Statistics, 1994; U.S. Department of Health and Human Services working paper series no. 7.
10. Nelson WW, Vermeulen LC, Geurkink EA et al. Clinical and humanistic outcomes in patients with gastroesophageal reflux disease converted from omeprazole to lansoprazole. Arch Intern Med. 2000; 160:2491-6.
11. Hospital statistics, 2001. Chicago: American Hospital Association; 2001.
12. American Society of Health-System Pharmacists. Drug shortages. www.ashp.org/shortage/ (accessed 2002 Aug 8).
13. Food and Drug Administration. Drug shortages. www.fda.gov/cder/drug/ shortages (accessed 2002 Aug 8).
14. Centers for Disease Control and Prevention. Current vaccine delays and shortages. www.cdc.gov/nip/news/shortages/default.htm (accessed 2002 Aug 8).
15. Kohn L, Corrigan J, Donaldson MS, eds. To err is human: building a safer health system. Washington, DC: National Academy Press; 2000.
16. American Society of Health-System Pharmacists. ASHP guidelines on quality assurance for pharmacy-prepared sterile products. Am J Health-Syst Pharm. 2000; 57:1150-69.
17. Bosso JA, Kokko H. Assessment of the impact of an antibiotic shortage: patient outcomes and cost. Hosp Pharm. 2004; 39:43-6.